Bati-on, Leslie S.

HRN: 22-77-38  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2023
CEFUROXIME 1.5GM (VIAL)
03/24/2023
03/25/2023
PO
1.5g
Q8 X 2 Kore Doses
Post CA
Waiting Final Action 
03/24/2023
CEFUROXIME 500MG (TAB)
03/24/2023
03/30/2023
ORAL
500mg
BID
Sp LTCS Thickly Msaf
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: